Tabuniag, Roselle .

HRN: 25-07-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
AMPICILLIN 1GM (VIAL)
07/13/2024
07/19/2024
IVT
2g
Q6hrs
PROM
Waiting Final Action 
07/14/2024
CEFUROXIME 500MG (TAB)
07/14/2024
07/20/2024
PO
500mg
BID
S/P RMLE With Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: